Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis

Rheumatology

Volumn 43, Issue 5, 2004, Pages 603-608

  Maillard, S M ^a,b   Jones, R ^b   Owens, C ^b   Pilkington, C ^a,b   Woo, P ^a,b   Wedderburn, L R ^a,b   Murray, K J ^a,b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

Childhood Myositis Assessment Scale; Juvenile dermatomyositis; Magnetic resonance imaging; Muscle inflammation

Indexed keywords

CREATINE KINASE; LACTATE DEHYDROGENASE; MUSCLE ENZYME;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DERMATOMYOSITIS; DISEASE ACTIVITY; HUMAN; IMAGE ANALYSIS; INFLAMMATION; MUSCLE FUNCTION; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; QUESTIONNAIRE; RELAXATION TIME; RELIABILITY; THIGH; VALIDATION PROCESS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; HUMANS; MAGNETIC RESONANCE IMAGING; MUSCLE, SKELETAL; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; THIGH;

EID: 2442606434     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh130     Document Type: Article

References (24)

1. Pachman LM. Juvenile dermatomyositis. Pediatr Clin North Am 1986;33:1097-117.
2. Petty RE, Cassidy JT. Textbook of Pediatric Rheumatology, 4th edn, Philadelphia, PA: W.B. Saunders, 2001:465-504.
3. Symmons DP, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol 1995;34:732-6.
4. Pachman LM. An update on juvenile dermatomyositis. Curr Opin Rheumatol 1995;7:437-41.
5. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). New Engl J Med 1975;292:344-7.
6. Lovell DJ, Lindsley CB, Rennebohm RM et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1999;42:2213-19.
7. Miller FW, Rider LG, Chung YL et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology 2001;40:1262-73.
8. Cawkwell GM. Inflammatory myositis in children, including differential diagnosis. Curr Opin Rheumatol 2000;12:430-4.
9. Chapman S, Southwood TR, Fowler J, Ryder CA. Rapid changes in magnetic resonance imaging of muscle during the treatment of juvenile dermatomyositis. Br J Rheumatol 1994;33:184-6.
10. Hernandez RJ, Keim DR, Chenevert TL, Sullivan DB, Aisen AM. Fat-suppressed MR imaging of myositis. Radiology 1992;182:217-19.
11. Hilario MO, Yamashita H, Lutti D, Len C, Terreri MT, Lederman H. Juvenile idiopathic inflammatory myopathies: the value of magnetic resonance imaging in the detection of muscle involvement. Sao Paulo Med J 2000;118:35-40.
12. Summers RM, Brune AM, Choyke PL et al. Juvenile idiopathic inflammatory myopathy: exercise-induced changes in muscle at short inversion time inversion-recovery MR imaging. Radiology 1998;209: 191-6.
13. Park JH, Vansant JP, Kumar NG et al. Dermatomyositis: correlative MR imaging and P-31 MR spectroscopy for quantitative characterization of inflammatory disease. Radiology 1990;177:473-9.
14. Feldman BM, Ayling-Campos A, Luy L et al. Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire. J Rheumatol 1995;22:326-31.
15. Florence JM, Pandya S, King WM et al. Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy. Phys Ther 1992;72:115-22.
16. Lennon SM, Ashburn A. Use of myometry in the assessment of neuropathic weakness: testing for reliability in clinical practice. Clin Rehab 1993;7:125-33.
17. Stark DD, Bradley WGJ. Magnetic resonance imaging yearbook, 2nd edn. Mosby, USA; 1999.
18. von Smekal A, Seelos KC, Kuper CR, Reiser M. Patient monitoring and safety during MRI examinations. Eur Radiol 1995;5:302-5.
19. Jackson GD. Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance. Neurology 1993;43:1793-9.
20. Hernandez RJ, Sullivan DB, Chenevert TL, Keim DR. MR imaging in children with dermatomyositis: musculoskeletal findings and correlation with clinical and laboratory findings. Am J Roentgenol 1993;161:359-66.
21. Reimers CD, Schedel H, Fleckenstein JL et al. Magnetic resonance imaging of skeletal muscles in idiopathic inflammatory myopathies of adults. J Neurol 1994;241:306-14.
22. May DA, Disler DG, Jones EA, Balkissoon AA, Manaster BJ. Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. Radiographics 2000;20:S295-S315.
23. Kimball AB, Summers RM, Turner M et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy. Arthritis Rheum 2000;43:1866-73.
24. Park JH, Vital TL, Ryder NM et al. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. Arthritis Rheum 1994;37:736-46.